HALO

#1033
Halozyme Therapeutics, Inc.
67.3100 USD
+0.49%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
67.3100
67.3100
Rango anual
61.2250
82.2200
Cambio diario
+0.49%
Variación mensual
+4.60%
Variación en los últimos 6 meses
+0.76%
Cambio anual
+0.76%
Cierres anteriores
66.9800
Abrir
67.3100
Bid
Ask
Mínimo
67.3100
High
67.3100
Volumen
115
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 202020212022202320242025 TTM

Halozyme Therapeutics Inc

Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California.

Noticias